Legend Biotech Corp - ADR Forecast, price target & analysts
Legend Biotech Corp - ADR Target price 2025 - Analyst rating & recommendation
Legend Biotech Corp - ADR Classifications & Recommendation:
Legend Biotech Corp - ADR Price Target
| Target Price | $76.82 |
| Price | $31.08 |
| Potential |
147.18%
register free of charge
|
| Number of Estimates | 22 |
|
22 Analysts have issued a price target Legend Biotech Corp - ADR 2026 .
The average Legend Biotech Corp - ADR target price is $76.82.
This is
147.18%
register free of charge
$95.00
205.66%
register free of charge
$55.00
76.96%
register free of charge
|
|
| A rating was issued by 26 analysts: 24 Analysts recommend Legend Biotech Corp - ADR to buy, 2 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Legend Biotech Corp - ADR stock has an average upside potential 2026 of
147.18%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 627.24 | 1,021.41 |
| 119.98% | 62.84% | |
| EBITDA Margin | -45.63% | -12.01% |
| 69.15% | 73.68% | |
| Net Margin | -28.40% | -5.71% |
| 85.00% | 79.89% |
23 Analysts have issued a sales forecast Legend Biotech Corp - ADR 2025 . The average Legend Biotech Corp - ADR sales estimate is
This results in the following potential growth metrics:
10 Analysts have issued an Legend Biotech Corp - ADR EBITDA forecast 2025. The average Legend Biotech Corp - ADR EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
11 Legend Biotech Corp - ADR Analysts have issued a net profit forecast 2025. The average Legend Biotech Corp - ADR net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.97 | -0.32 |
| 67.01% | 67.01% | |
| P/E | negative | |
| EV/Sales | 4.83 |
11 Analysts have issued a Legend Biotech Corp - ADR forecast for earnings per share. The average Legend Biotech Corp - ADR EPS is
This results in the following potential growth metrics and future valuations:
Legend Biotech Corp - ADR...
Current Legend Biotech Corp - ADR Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| RBC Capital |
Locked
➜
Locked
|
Locked | Apr 22 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Apr 16 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Apr 08 2025 |
| Morgan Stanley |
Locked
➜
Locked
|
Locked | Mar 17 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Mar 12 2025 |
| Guggenheim |
Locked
➜
Locked
|
Locked | Mar 12 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Jan 23 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
RBC Capital:
Locked
➜
Locked
|
Apr 22 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Apr 16 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Apr 08 2025 |
|
Locked
Morgan Stanley:
Locked
➜
Locked
|
Mar 17 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Mar 12 2025 |
|
Locked
Guggenheim:
Locked
➜
Locked
|
Mar 12 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Jan 23 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
